Hostname: page-component-84b7d79bbc-x5cpj Total loading time: 0 Render date: 2024-07-28T16:36:00.394Z Has data issue: false hasContentIssue false

Burning Mouth Syndrome: Problem in the Mouth?

Published online by Cambridge University Press:  23 March 2020

S. Petrykiv
Affiliation:
University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands
L. de Jonge
Affiliation:
Leonardo Scientific Research Institute, Department of Geriatric Psychiatry, Groningen, The Netherlands
M. Arts
Affiliation:
University Medical Center Groningen, Department of Old Age Psychiatry, Groningen, The Netherlands

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Burning mouth syndrome (BMS) is characterized by an intraoral burning sensation for which no medical or dental cause can be found. Sporadic evidence suggests that drug induced conditions may evoke BMS. Intriguingly, we observed a patient who developed BMS after induction of citalopram.

Objectives & aims

A case report of patient with BMS from our psychiatric ward will be presented here, followed by a literature review on drugs induced BMS.

Methods

Based on a recent literature search, we present a first case report of BMS that was apparently induced in patient shortly after beginning of citalopram. We performed a systematic search through PubMed, EMBASE and Cochrane's Library to find more cases of psychotropic induced BMS.

Results

Ms. A. was a 72-year old woman meeting DSM-IV diagnostic criteria for melancholic depression, who was observed in a clinical setting. We started citalopram 10 mg. 1dd1, with 10 mg. 1dd1 increase over 7 days to 20 mg, 1dd1. The following day, she displayed a persistent burning painful sensation in the mouth. Other than BMS oropharyngological syndromes were excluded after consultation with qualified medical specialists. Citalopram therapy was discontinued, and nortrilen treatment was initiated. BMS symptoms resolved over four days. Twelve case reports have linked BMS to the use antidepressants and anxiolytics.

Conclusion

Contrasting the statement that no medical cause can be found for BMS, we found that psychotropics may evoke the syndrome. Compared to other psychotropic drugs, antidepressant medication has the strongest association with BMS.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
e-Poster Walk: Oncology and Psychiatry and Pain and Treatment Options
Copyright
Copyright © European Psychiatric Association 2017
Submit a response

Comments

No Comments have been published for this article.